When drug nanocarriers miss their target: extracellular diffusion and cell uptake are not enough to be effective-Reference-Cited by-同舟云学术

When drug nanocarriers miss their target: extracellular diffusion and cell uptake are not enough to be effective

Published:2021 Issue:16 Volume:9 Page:5407-5414
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Pautu Vincent¹²³⁴⁵^ORCID,Zhao Heng⁶⁷⁸³⁹^ORCID,Mielcarek Angelika⁶⁷⁸³⁹^ORCID,Balasso Anna¹²³⁴⁵^ORCID,Couvreur Patrick¹²³⁴⁵^ORCID,Serre Christian⁶⁷⁸³⁹^ORCID,Mura Simona¹²³⁴⁵^ORCID

Affiliation:

1. Institut Galien Paris-Saclay

2. UMR 8612

3. CNRS

4. Université Paris-Saclay

5. Faculté de Pharmacie

6. Institut des matériaux poreux de Paris

7. Ecole normale supérieure

8. ESPCI Paris

9. PSL University

Abstract

Screening on a relevant 3D tumor model enabled to discard unpromising nanocarriers and may help their opportune optimization to successfully reach the target.

Funder

Centre National de la Recherche Scientifique

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2021/BM/D1BM00669J

Reference41 articles.

1. Emerging Frontiers in Drug Delivery

2. Clinical cancer nanomedicine

3. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery

4. Current trends in the use of liposomes for tumor targeting

5. The role of liposomes in clinical nanomedicine development. What now? Now what?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicellular tumor spheroid model to study the multifaceted role of tumor-associated macrophages in PDAC;Drug Delivery and Translational Research;2023-12-07

2. Heterotypic tumor spheroids: a platform for nanomedicine evaluation;Journal of Nanobiotechnology;2023-08-02

3. Novel adjuvant nano-vaccine induced immune response against Acinetobacter baumannii;AMB Express;2023-03-11

4. Before in vivo studies: In vitro screening of sphingomyelin nanosystems using a relevant 3D multicellular pancreatic tumor spheroid model;International Journal of Pharmaceutics;2022-04